Reflect Scientific, Inc.
RSCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,681 | $5,054 | $4,069 | $3,598 |
| - Cash | $1,678 | $1,299 | $1,079 | $1,014 |
| + Debt | $138 | $141 | $161 | $180 |
| Enterprise Value | $3,141 | $3,896 | $3,151 | $2,763 |
| Revenue | $400 | $280 | $368 | $344 |
| % Growth | 42.8% | -24% | 7.1% | – |
| Gross Profit | $229 | $180 | $142 | $58 |
| % Margin | 57.3% | 64.4% | 38.6% | 16.9% |
| EBITDA | $51 | -$16 | $75 | $1 |
| % Margin | 12.7% | -5.6% | 20.4% | 0.3% |
| Net Income | $41 | -$6 | $56 | -$18 |
| % Margin | 10.3% | -2.1% | 15.2% | -5.2% |
| EPS Diluted | 0.001 | -0 | 0.001 | -0 |
| % Growth | 600% | -114.3% | 450% | – |
| Operating Cash Flow | – | – | $64 | – |
| Capital Expenditures | – | – | $0 | – |
| Free Cash Flow | – | – | $64 | – |